(Q54549907)

31 May 2018

title

Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. (English)

1 reference

31 May 2018

0 references

Jodi Speiser

1

1 reference

31 May 2018

Kimberly Foreman

2

1 reference

31 May 2018

Eva Drinka

3

1 reference

31 May 2018

Constantine Godellas

4

1 reference

31 May 2018

Claudia Perez

5

1 reference

31 May 2018

Alia Salhadar

6

1 reference

31 May 2018

Çağatay Erşahin

7

1 reference

31 May 2018

Prabha Rajan

8

1 reference

31 May 2018

publication date

13 November 2011

1 reference

31 May 2018

International Journal of Surgical Pathology

published in

1 reference

31 May 2018

volume

20

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

139-145

1 reference

31 May 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

A functional Notch-survivin gene signature in basal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch signaling: cell fate control and signal integration in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch signalling: a simple pathway becomes complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Is there a role for Notch signalling in human breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch signaling in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

High-level JAG1 mRNA and protein predict poor outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Notch-1 and notch-4 receptors as prognostic markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Impact of body mass index on clinical outcomes in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

Activated checkpoint kinase 2 provides a survival signal for tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

A p34(cdc2) survival checkpoint in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896911427035

21 January 2018

Identifiers

DOI

10.1177/1066896911427035

1 reference

31 May 2018

1 reference

31 May 2018